This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Raqualia Pharma Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Mitsuhiro Fujishiro: Innovator in Cancer Treatment
Introduction
Mitsuhiro Fujishiro is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on improving therapeutic strategies for cancer patients, particularly through combination therapies.
Latest Patents
Fujishiro holds a patent for a method that selects cancer patients for whom combination therapy with a retinoid and a cancer therapeutic agent is effective. The patent, titled "Method for selecting cancer patients for whom combination therapy with retinoid and cancer therapeutic agent is effective, and combination medicament with retinoid and cancer therapeutic agent," outlines a process that identifies patients with malignant tumors that have infiltration of cancer-associated fibroblasts in the stroma. This innovative approach aims to enhance the efficacy of cancer treatments.
Career Highlights
Fujishiro is associated with Raqualia Pharma Inc., where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment. With 1 patent to his name, he is recognized for his contributions to medical science.
Collaborations
Fujishiro has collaborated with notable colleagues, including Tadashi Iida and Atsushi Enomoto. Their combined expertise has furthered the development of innovative cancer treatment strategies.
Conclusion
Mitsuhiro Fujishiro's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His dedication to improving therapeutic methods highlights the importance of research and collaboration in advancing healthcare solutions.